KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Short-Term Debt issuances: 2020-2025

Historic Short-Term Debt issuances for Idexx Laboratories (IDXX) over the last 3 years, with Sep 2025 value amounting to -$124.0 million.

  • Idexx Laboratories' Short-Term Debt issuances was N/A to -$124.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $191.0 million, marking a year-over-year change of. This contributed to the annual value of -$329.0 million for FY2023, which is 165.08% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Short-Term Debt issuances is -$124.0 million, which was down 147.78% from $259.5 million recorded in Q2 2025.
  • Idexx Laboratories' Short-Term Debt issuances' 5-year high stood at $326.5 million during Q1 2022, with a 5-year trough of -$167.5 million in Q2 2023.
  • Its 2-year average for Short-Term Debt issuances is -$20.7 million, with a median of -$69.0 million in 2023.
  • Data for Idexx Laboratories' Short-Term Debt issuances shows a maximum YoY plummeted of 179.38% (in 2023) over the last 5 years.
  • Idexx Laboratories' Short-Term Debt issuances (Quarterly) stood at -$54.0 million in 2022, then tumbled by 163.64% to -$14.0 million in 2023, then reached -$124.0 million in 2025.
  • Its Short-Term Debt issuances stands at -$124.0 million for Q3 2025, versus $259.5 million for Q2 2025 and $69.5 million for Q1 2025.